Common Contracts

EXCLUSIVE LICENSE AGREEMENT BETWEEN SALK INSTITUTE FOR BIOLOGICAL STUDIES AND ACCELERON PHARMA INC. ACTIVIN RECEPTORS (TYPE IIB) AND RELATED SUBJECT MATTER FOR THERAPEUTIC AND DIAGNOSTIC PURPOSES

Exclusive License Agreement • August 7th, 2013 • Acceleron Pharma Inc • Biological products, (no disgnostic substances) • California

• Contract Type
  Exclusive License Agreement
• Filed
  August 7th, 2013
• Company
  Acceleron Pharma Inc
• Industry
  Biological products, (no disgnostic substances)
• Jurisdiction
  California

This Amended and Restated License Agreement (the “Agreement”) is made and entered into as of August 11, 2010, (the “Effective Date”) by and between the Salk Institute for Biological Studies, a nonprofit public benefit corporation organized under the laws of the State of California (“Salk”), and Acceleron Pharma, Inc., a corporation organized under the laws of the State of Delaware (“Licensee”).

EXCLUSIVE LICENSE AGREEMENT BETWEEN SALK INSTITUTE FOR BIOLOGICAL STUDIES AND ACCELERON PHARMA INC. ACTIVIN RECEPTORS (TYPE IIA) AND RELATED SUBJECT MATTER FOR THERAPEUTIC AND DIAGNOSTIC PURPOSES

Exclusive License Agreement • August 7th, 2013 • Acceleron Pharma Inc • Biological products, (no disgnostic substances) • California

• Contract Type
  Exclusive License Agreement
• Filed
  August 7th, 2013
• Company
  Acceleron Pharma Inc
• Industry
  Biological products, (no disgnostic substances)
• Jurisdiction
  California

This Amended and Restated License Agreement (the “Agreement”) is made and entered into as of August 10, 2010, (the “Effective Date”) by and between the Salk Institute for Biological Studies, a nonprofit public benefit corporation organized under the laws of the State of California (“Salk”), and Acceleron Pharma, Inc., a corporation organized under the laws of the State of Delaware (“Licensee”).